Patents Assigned to Brandels University
  • Patent number: 9408921
    Abstract: Disclosed is a general methodology to create nanofibers of therapeutic molecules that have a dual role, as both the delivery vehicle and the drug itself. It is shown that with proper molecular design, the integration of enzymatic reaction and self-assembly provides a powerful method to create molecular hydrogels of clinically-used therapeutics without compromising their bioactivities. In addition, the results disclosed herein demonstrate enzyme-instructed self-assembly as a facile strategy for generating the supramolecular hydrogels of molecules that inherently have poor solubility in water. For example, by covalently connecting paclitaxel with a motif that is prone to self-assemble, a hydrogel of paclitaxel can be formed without compromising the activity of the paclitaxel.
    Type: Grant
    Filed: February 25, 2014
    Date of Patent: August 9, 2016
    Assignee: Brandels University
    Inventors: Yuan Gao, Yi Kuang, Bing Xu
  • Publication number: 20100260718
    Abstract: The invention relates to methods for treating BCR/ABL mediated disorders. The methods of the invention also include monitoring progression of or sensitivity to treatment of BCR/ABL mediated disorders as well as identifying subjects for the treatment methods of the invention. Screening assays and related products and kits are also encompassed within the invention.
    Type: Application
    Filed: December 10, 2008
    Publication date: October 14, 2010
    Applicant: Brandels University
    Inventor: Ruibao Ren